COVESTRO AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.75 USD | +0.44% |
|
-0.23% | -11.86% |
| Apr. 17 | Covestro Says No Deadline to Conclude ADNOC talks, to Take the Necessary Time to Conclude ADNOC talks | CI |
| Apr. 17 | Covestro takeover by oil group Adnoc still up in the air | DP |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 52.08 times its estimated earnings per share for the ongoing year.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -11.86% | 9.66B | - | ||
| +4.47% | 39.69B | B- | ||
| -25.15% | 20.62B | B- | ||
| -14.52% | 13.26B | B- | ||
| -13.48% | 9.69B | B+ | ||
| -4.50% | 6.56B | C+ | ||
| +3.01% | 6.12B | C+ | ||
| -30.31% | 5.28B | C | ||
| -14.67% | 3.47B | A | ||
| -34.73% | 3.08B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 1COV Stock
- COVTY Stock
- Ratings Covestro AG
